Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Artesunate-amodiaquine and Dihydroartemisinin-piperaquine for the Treatment of Uncomplicated Falciparum Malaria in Mainland Tanzania

NCT03431714 is registered in ClinicalTrials.gov with National Institute for Medical Research, Tanzania as lead sponsor.

NCT NCT03431714
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03431714 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Artesunate-amodiaquine and Dihydroartemisinin-piperaquine for the Treatment of Uncomplicated Falciparum Malaria in Mainland Tanzania
Lead sponsor
National Institute for Medical Research, Tanzania
Phase
Phase 4
Overall status
Completed
Start date
July 14, 2017
Completion date
December 8, 2017
Enrollment
333 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

uncomplicated falciparum malaria